Intrinsiqq
Bodhi Tree Biotechnology Inc logo

Bodhi Tree Biotechnology Inc

BDTB
⊜ Compare
ProfitabilityUnprofitableGrowthN/ACash FlowN/AValuationN/A
What stands out

The business is unprofitable at the operating level (-868.34% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.

What deserves caution

Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.

Profitability & Returns

Revenue (TTM)

$37K

Net Income (TTM)

-$116K

Op. Margin

-310.18%

ROIC

-153.53%

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$116K

Net Debt

-$4K

Net Cash Position

Cash & Equiv.

$4K

Continue Research

SourceComputed from the 10-Q filed 14 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 17 Sept 2026. How this is calculated.

Fiscal year ends Sep. Sector medians are approximate S&P 500 benchmarks and update periodically.

Related stocks: Services-Management Consulting Services

Spot a number that looks wrong? Check it in BDTB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BDTB

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.